BearDownAZ,

Good news for the trial that low HDL increases MACE events.

I think my problem in understanding all this is that in most Bio's I have invested in the past, the Placebo results were pretty constant.

In the BETonMACE the placebo results are an unknown going in, so when we get info that the MACE events are at 7.2% as of june 2018,...we still cannot figure out what MACE event rate is for our drug,...

But if we were to assume that the Placebo results are actually around 11%-12% percent in this trial,... and we assume also that the 7.2% MACE event rate is coorect as of June 2018,... with that info and those assumptions,... is it possible to calculate the RRR% of RVX-208,... would it be close to 30%,..?

Much appreciated!